Hjem › Kolesterol › Texas
Kolesterol kliniske forsøg i Texas
6 studier for Kolesterol søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- PharmaTex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Inc., Amarillo
- Austin Heart, Austin
- og 8 flere
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- og 3 flere
RekruttererFase 3
Alder 18 til 130 · Alle køn · Opdateret 10. sep. 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Synergy Group Medical LLC, Houston
- Synergy Group Medical LLC, Houston
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 30. jul. 2026 · NCT07610278A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Velocity Clinical Research Dallas, Dallas
- Valley Institute of Research, Rockwood Medical Clinic, Fort Worth
- Be Well Clinical Studies - Round Rock, Round Rock
- og 3 flere
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. jul. 2026 · NCT07477704Multicomponent Intervention Study- Blood Donors With High Cholesterol
- UT Southwestern Medical Center, Dallas
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 17. mar. 2026 · NCT05693701Alirocumab in Patients on a Stable Dialysis Regimen
- Baylor Soltero CV Research, Dallas
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 12. feb. 2020 · NCT03480568Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.